Secretome Therapeutics

About Secretome Therapeutics

Secretome Therapeutics is a pioneering company focused on developing novel therapies using neonatal cardiac progenitor cells (nCPCs) to address unmet medical needs in cardiovascular and inflammatory diseases, particularly heart failure.

Products & Services

STM-01:A lead drug derived from neonatal cardiac progenitor cells (nCPCs) with high potency for regenerative therapies, outperforming adult-derived stem cells.

STM-21:A secretome product derived from neonatal sources, ensuring minimal variability and supporting scalable stem cell-based therapies.

Investigational Medicine for HFpEF:An early-stage treatment for heart failure with preserved ejection fraction, currently in clinical trials.

STM-01

STM-2

Specialties

Neonatal Cardiac Progenitor Cells (nCPCs) Stem Cell-Based Therapies Cardiovascular Therapies Heart Failure Treatment Inflammatory Disease Treatment Neonatal cardiac progenitor cells Regenerative medicine Secretome therapies Heart failure treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 30000000 MR: - FA: $30 Million FAN: 30000000	D: 2026-05-27 FD: 2026-05-27	1 investors
2	RT: Venture Philanthropy T: - FT: Venture Philanthropy	A: 250000 MR: - FA: $250,000 FAN: 250000	D: 2026-03-24 FD: 2026-03-24	1 investors
3	RT: Financing Round T: - FT: Financing Round	A: 20400000 MR: - FA: $20.4 million FAN: 20400000	D: 2024-11-25 FD: 2024-11-25	-
4	RT: SPV T: - FT: SPV	A: 1800000 MR: - FA: $1.8 million FAN: 1800000	D: 2024-09-17 FD: 2024-09-17	1 investors

Series A Latest

2026-05-27

$30.0M

1 investor (Pro only)

Venture Philanthropy 2026-03-24

$250K

Financing Round 2024-11-25

$20.4M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

V

Vinny Jindal

Co-founder, Board Member, President & CEO

M

Marshelle Smith

Chief Development Officer

J

Jeff Masten

Chief Technical Officer

M

Malika Pasha

Vice President, Clinical Operations

P

Preston Daniels

Vice President, Strategy

R

Rachana Mishra

Senior Director of CMC

View 24 more team members with Pro

Unlock Full Team Directory

Recent News